Catheter Ablation
Treatment for Atrial Fibrillation
Effectiveness
75%
Safety Score
60%
Clinical Trials
869
Participants
50K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Time to Effect
3-6 months for full effect assessment
Treatment Duration
Single procedure, possibly repeat
Evidence Quality
HIGHNumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,500
Side Effect Mgmt:$500
Total Annual:$9,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$55,000/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$12,000
Cost per Remission
$13,846
Comparison vs Amiodarone
Cost Difference
+$5,000/year
More expensive
QALY Difference
+0.15 QALYs
Better outcomes
Dominance
No dominance
Catheter Ablation Outcomes
for Atrial Fibrillation
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+75%
Remission Rate
+65%
Common Side Effects
Groin hematoma/bleeding
+3%
Cardiac tamponade
+1.5%
Stroke/TIA
+0.5%
Pericarditis
+3%
Sources:
Active Clinical Trials
3 active trials recruiting for Catheter Ablation in Atrial Fibrillation
Real-world Experience of Catheter Ablation Using Novel Ablation Technologies for the Treatment of Atrial Fibrillation
NCT05006456NOT YET RECRUITING
4K participants
OBSERVATIONAL
Started: Jan 1, 2022
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation
NCT03347227RECRUITINGNA
502 participants
INTERVENTIONAL
Calgary, Canada +14 more
Started: Aug 24, 2018
Evaluation of Ablation Lesions Using Cardiovascular Magnetic Resonance Imaging
NCT05432024RECRUITING
60 participants
OBSERVATIONAL
Nieuwegein, Netherlands
Started: Mar 8, 2023
Completed Clinical Trials
8 completed trials for Catheter Ablation in Atrial Fibrillation
Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion
NCT05477147COMPLETEDNA
96 participants
INTERVENTIONAL
Birmingham, United States +18 more
Started: Mar 17, 2023
DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation
NCT03334630COMPLETEDNA
482 participants
INTERVENTIONAL
Birmingham, United States +22 more
Started: Nov 6, 2017
Catheter Ablation for Atrial Fibrillation in Preserved Ejection Fraction
NCT04317911COMPLETED
102 participants
OBSERVATIONAL
Heidelberg, Germany
Started: Jan 26, 2016
Remote MAGNetic Catheter Ablation for Atrial Fibrillation
NCT02587624COMPLETED
804 participants
OBSERVATIONAL
Nuremberg, Germany
Started: Mar 1, 2011
Hybrid Versus Catheter Ablation in Persistent AF
NCT02441738COMPLETEDNA
41 participants
INTERVENTIONAL
Maastricht, Netherlands
Started: Oct 31, 2016
Biomarkers in Patients Undergoing Atrial Fibrillation Ablation
NCT03388333COMPLETED
300 participants
OBSERVATIONAL
Hamburg, Germany
Started: Jan 1, 2017
Safety and Efficacy of Persistent Atrial Fibrillation Ablation With a Cryoballoon Technology
NCT06567652COMPLETED
80 participants
OBSERVATIONAL
Brussels, Belgium
Started: Jan 1, 2021
Feasibility of Pulsed Field Ablation Under Mild Conscious Sedation
NCT06014814COMPLETED
40 participants
OBSERVATIONAL
Liverpool, United Kingdom
Started: Aug 21, 2023
Showing 20 of 889 total trials